Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration

Posted on by

PRINCETON, N.J., March 16, 2023 /PRNewswire/ — Geistlich Pharma North America Inc. is pleased to introduce a growing variety of vallos® allograft configurations to increase treatment flexibility through its partnership with a world leading allograft provider. Geistlich Pharma North…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.